Common Contracts
2 similar License and Option Agreement contracts by Coley Pharmaceutical Group, Inc.
EX-10.2 2 dex102.htm LICENSE AND OPTION AGREEMENT, DATED AS OF APRIL 11, 2007 EXECUTION COPY Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting...License and Option Agreement • May 5th, 2020 • New York
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934.
Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 24b-2 of the Exchange Act. LICENSE AND OPTION AGREEMENT by and...License and Option Agreement • August 8th, 2007 • Coley Pharmaceutical Group, Inc. • Pharmaceutical preparations • New York
THIS LICENSE AND OPTION AGREEMENT (this “Agreement”) is entered into as of April 11, 2007 (the “Effective Date”), by and between COLEY PHARMACEUTICAL GROUP, INC., a Delaware corporation having an address of 93 Worcester Street, Suite 101, Wellesley, Massachusetts 02481 (“Coley”) and MERCK AND CO, INC., a corporation organized and existing under the laws of New Jersey, with its principal business office located at One Merck Drive, P.O. Box 100, Whitehouse Station, New Jersey 08889 (“Merck”). Each of Merck and Coley is sometimes referred to individually herein as a “Party” and collectively as the “Parties”.
